Washington State Opioid Misuse.edited
docx
keyboard_arrow_up
School
Walden University *
*We aren’t endorsed by this school
Course
4200
Subject
Medicine
Date
Apr 3, 2024
Type
docx
Pages
10
Uploaded by shalandap90
1
Washington State Policies to Prevent Prescription Opioid Misuse and Abuse
Walden University
Abstract
Opioid Addiction is assuming control in numerous states. Because of this expansion of overdoses
of opioids, a few states have received models to control the restorative board recommending approaches, the organization of medicine checking programs, rules about documentation necessities, and different measures. Opioid Addiction affects families, the network alongside causing a high rate of fatalities.
Government authorities in Washington State started to center around heroin and opioid mishandle approaches to battle the war on opioid abuse. The motivation behind this investigation
is to address, the Prescription Opioid Addiction, and Misuse.
Washington State Policies to Prevent Prescription Opioid Misuse and Abuse
STATEMENT OF THE PROBLEM
Today, opioids will be used to treat pain and conditions associated with pain. Providers prescribe
these drugs as a temporary option. However, it is reported that more than 100,000 people in the United States died from prescribed opioids. Policies for prescribing opioids have changed in the late 1990's (Paulozzi LJ, Jones C, Mack K, Rudd R., 2011). During this time, patient advocacy groups along with pain management specialist were successful when it came to lobbying with the
state medical boards and state legislatures to enforce change along with regulations to lift the prohibition of opioid usage for those noncancer patients (Rosenblum, A. et al., 2008). There were about 20 states, with new federal guidelines, regulations, laws, and statutes. The laws were very liberalized, they provided a long-term usage of opioids for chronic noncancer pain, around this time they believed there was no clinical max on opioid dosing (Chou, R. et al., 2009).
This analysis will focus on Washington State policy of prescribing opioids for pain management of non -cancer patients. In the Washington State Administrative Code (WAC) 246-919-830 says "no disciplinary action will be taken against a practitioner based solely on the quantity or frequency of opioids prescribed," since 1999, this law was repealed (Oputm, 2016). By 2006, Washington State along with the Centers for Disease Control and Prevention identified a high mortality rate in this state of 10.8 death/100 000 due to the unintended drug (Warner M. et al., 2009). The primary role of States is to protect the public, provide safety, regulate health care and its practices, and manage the disbursement of prescribed opioids a by using a drug monitoring program. It is a very critical to address prescription drug misuse at a state level for each state may use different guidelines, regulations and laws to combat this epidemic.
SYNTHESIS OF AVAILABLE EVIDENCE
With the acceleration of opioid death, you can say it's a national epidemic and public health problem . Many systemic reviews conducted will begin to assess the efficacy and effectiveness of opioid prescription for chronic noncancer pain. In these findings, the efficiency for treatment was limited, there's a misuse of opioids, and its improvement for the patient/consumer had a small percentage, and it was determined that opioids as treatment are a poor way to treat pain (Franklin, G et al., 2015).
Many states often emphasize the importance of prevention for illicit drug misuse. However, another state would encourage an appropriate pain management solution this will eliminate having a burden on the providers and patients (Crowley R et al., 2017). All state did their very own thing in combatting opioid misuse, for example, some had followed the advice of specialty societies. In 2007, Washington State began to address the epidemic of opioid-related morbidity and mortality. The state will use experiences of informative policy guidelines to govern its policy. The policies will engage all public state, local and federal agencies. These agencies collaborated alongside several academic and practicing pain management providers who would communicate opioid guidelines in the community. Agencies main recommendation was to guarantee a consultation with the patient/ consumer when they reach over 120 morphine milligram a day and with no improvement for pain or function (Chou R, Deyo R, Devine B, et al., 2017). Several states, including the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ), had universal precautions which were
adopted (Chou R, Deyo R, Devine B, et al., 2017).
Hence, the CDC and other organizations have engaged in more evidence-based guidelines for prescription misuse and addiction; the question lies in how can Washington State ensure that its states guidelines can reduce the total of over-prescribed opioids for pain management and chronic pain?
BACKGROUND
In Washington State, the opioid pandemic is pulverizing families and overpowering law enforcement and social administrations. Washington State experienced more than 700 opioid-
related deaths in 2015, due to drug poisoning and overdose (Washington State Department of Health., 2015). However, Washington State has a decrease in prescription-related deaths. Prescription deaths from opioids are most astounding in the 45 to 54 age groups (Franklin, Gary, et al. 2015). For the age group of 25 to 34, they have a more heroin demise rate (Franklin, Gary, et al. 2015). Washington State was the first states in the country to create guidelines for opioid endorsing. Washington State even made a Statewide Opioid Response Plan and extended access to treatment for sedative utilize issue, and the overdose anticipation tranquilizes, naloxone Franklin, Gary, et al. 2015).
In recent decades, family doctors have perceived that there has been an expanded accentuation on the acknowledgment of pain and the absence of proper care. For this reason, the U.S. Congress than announced the Decade of Pain Control and Research, (Paulozzi LJ, Jones C, Mack
K, Rudd R., 2011). Numerous experts, including the American Academy of Pain Medicine, the American Pain Society, the American Headache Society, and others, were established to enhance
pain management and enhance the preparation of doctors who oversee pain management (Paulozzi LJ, Jones C, Mack K, Rudd R., 2011).
Providers often prescribe opioids for pain. Pain is the number one reason there are medical visits and why many patients are on opioids. Chronic pain is a burden on humans, it cost millions in health care, and it is a public health issue. Hence, the utilization of chronic opioid treatment was genuinely held for patients with cancer or end-of-life pain (Chou, R. et al., 2009). The move toward more liberal utilization of opioids for constant, noncancer pain (CNCP) started in the mid-to-late 1980s when an early case arrangement recommended that patients with CNCP, if well picked, could take opioids long haul securely and with the couple of serious issues (Belgrade MJ et al., 2006). Based on several studies, pain management groups and specialist looked for state-based administrative changes to turn around the apparent undertreatment of chronic pain ( Belgrade MJ et al., 2006). These associations energetically campaigned state medical boards and its legislation to change statutes and controls to guarantee more tolerant utilization of opioids in the CNCP population and to lessen the danger of endorse for prescribers.
By January 2003, just five states and the District of Columbia had not changed their statutes or regulations (Butler SF et al., 2007).
Soon after, the Joint Commission made development for pain as the fifth vital sign. Using the fifth vital sign expanded opioid prescribing for intense pain in the clinic setting, particularly in emergency rooms (Poon, Sabrina J. et al., 2014). The pain was scaled using a numeric pain intensity score was a metric for assessing "pain" in the hospital (Poon, Sabrina J., et al., 2014). Studies have discovered that these progressions have not changed in nature of pain management,
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
yet it may cause more of adverse opioid responses in hospitals and may have added to more hazardous levels of postoperative sedation (Poon, Sabrina J., et al., 2014).
Even with the fifth vital sign used, Washington State saw an increase of opioid prescribing expanded 500% from 1997 to 2006 (Franklin, G et al., 2015). From 1996 until 2002, The Washington workers' compensation system saw a high increase in plan II opioid prescribing and a half increment in the normal every day morphine-identical dosage (MED) among harmed workers taking these powerful medications (Franklin, G et al., 2015). In 2000, workers' compensation program noticed an ascent in overdose deaths (Franklin, G et al., 2015). These deaths incited a manual audit of all opioid overdose death certificates by the Washington Department of Health. The underlying survey demonstrated an expansion in the number of overdose deaths including solution opioids from 24 in 1995 to 351 out of 2004 (Franklin, G et al., 2015).
Since than policies changed. The pharmaceutical industry begins to become an aggressive market, and it led to a high increase amongst prescription sales of opioids. In studies, you will see a linear correlation between mortality and sales of certain prescribed opioids. Many deaths seem to be poignant; this is because many younger adults are affected (Franklin, G et al., 2015). A young adult between 35-54 years of age, had a higher risk of opioid overdose.
Landscape
In 2008, the Department of Health gathered an Unintentional Poisoning Workgroup to address the disturbing increment in overdose deaths caused by prescribed opioids (Washington State Health, 2016). Years later, overdose death was only identified with heroin usage, the office extended the focal point of the groups to incorporate overdose deaths identified with an opioid and changed the name of the workgroup to the Opioid Response Workgroup (King, N. B., 2014).
By 2015, the Opioid Response Workgroup teamed up to build up an extensive statewide opioid reaction design (Washington State Health, 2016). On September 30, 2016, Governor Jay Inslee marked Executive Order 16-09, Addressing the Opioid Use Public Health Crisis, formally guiding state organizations to actualize critical components of the Washington State Opioid Response Plan. The workgroup refreshes the arrangement yearly to line up with the advancement
of the issue, changing logical confirmation, new approaches actualized by the lawmaking body, and new exercises bolstered by state and government financing (Washington State Health, 2016).
Many stakeholders are involved in opioid prescription misuse. Washington State stakeholder use for strategies which are the following:
Forestall opioid abuse and mishandle
Distinguish and treat opioid use disorder
Have a reduction of morbidity and mortality from opioid use
Utilize information and data to identify opioid abuse/misuse, screen morbidity, and mortality, and assess interventions (Washington State Health, 2016).
The Bree Collaborative Opioid Prescribing Implementation Workgroup (2015), has built up an arrangement of statewide opioid prescribing metrics primary in following state progress. Metrics
are intended to help with effective techniques to intercede in prescribing practice, giving guidance for several health plans, health systems, and individual providers to enhance the quality
of care (The Bree Collaborative, 2015). The draft metrics spread to the more extensive public health period will be introduced to the Bree Collaborative (2015). The workgroup is teaming up with Oregon Health Authority for conceivable reception of the metrics and is additionally in network with the Centers for Disease Control and Prevention about appropriation Partners from all divisions on the neighborhood, state and government levels are driving execution of the techniques and exercises in the reaction design (The Bree Collaborative, 2015). The following partner and stakeholders all have communicated a specific intrigue and duty of tending to opioid abuse and overdose anticipation. Stakeholders had the support of an assortment of a neighborhood supports stakeholders, state and government subsidizing sources.
Prescribed Opioid Misuse has become a public health epidemic; stakeholders have scurried to implement strategies to reduce prescribing opioids along with best practices that promote risk management form harms of opioids harms. It best for the stakeholder to make these efforts in the
beginning stages of implementations, that has evaluations for guidelines that are focused on changing how the patient/consumer behavior is towards the prescribed medicine.
A few studies evaluated the effect of such interventions on patient/consumer safety, pain management, or avoidance of adverse outcome (Franklin, G et al., 2015). Regardless of these limits, a few endeavors are in progress to all the more likely comprehend the effect of safe prescribing methods on downstream health results and public health. As of October 2017, the Patient-Centered Outcomes Research Institute (PCORI) provided funds for comparative clinical research studies which are related to chronic pain management and opioid misuse (PDMP, 2017). Many of these studies address a provider target intervention to control and prevent unsafe opioid prescribing and prescription opioid management in chronic pain.
Optional Analysis
Misusage of opioids is the main reasonings of this epidemic. With so many people using drugs such as heroin and fentanyl, research shows that the illicit users continuously misuse prescribed opioids. According to the Centers for Disease Control and Prevention (2011), there has been a massive increment in opioid medicines for pain since 1999, yet the amount of pain that Americans report has not changed much overall. While the new research found that the number of opioids prescribed had a decline in 2010 and 2015, it remain about three times higher than in 1999 (CDC, 2011).
Because of the opioid epidemic, the "Rule for Prescribing Opioids for Chronic Pain" released by the CDC, (2016). This guideline is for the primary care providers, and it's an evidence-based recommendation when giving opioids to patients 18 years or older (CDC, 2016). Primarily the focus is on chronic pain treatment and doesn't apply to an active cancer patient in treatment, or end of life care. The suggestions depend on existing evidence. For instance, higher dosages of opioids relate to the higher danger of overdose and death (CDC, 2016). Indeed, even moderately low doses—thought to be 20 to 50 morphine milligram (MME) every day—can be a hazard (CDC, 2016). The CDC (2016), recommended starting with lower dosages. When considering doses over 50 or 90 MMEs every day, they should be given carefully (CDC, 2016). For treating acute pain, the rule prescribes an amount no more prominent than what requires for the average
length of pain sufficiently extreme to require opioids, determining that three days or less will regularly be adequate and over seven days will once in a while be required.
Utilizing opioids to treat acute pain can prompt long-term use. Truth be told, when opioids are used after the third and fifth day can cause the spike in long time usage (CDC, 2016). Once it reaches the 31st day, its determined that one could be addicted. The CDC, follow up saying that long-time users will also increase once the second prescription or refill with a 700 morphine milligram (MME) cumulative dose, and an underlying 10-or 30-day supply (CDC, 2016).
Enhancing prescribing practices and the manner in which pain treatment is successful will lead one road to help avoid abuse, addiction, and overdose. In recent years, various states have ordered approaches identified with prescribing opioids, some of which line up with specific suggestions in the CDC Guideline.
In 2016, the state started working with network offices to create and execute an exhaustive technique to spare lives by ceasing opioid habit in Washington State. Together, they made the Washington State Opioid Response Plan.
Since the Governor placed an initiative in 2016, providers have worked determinedly to authorize these and numerous different changes to the manner in which the Washington State drug recovery rehab could combat the opioid epidemic. With deaths from overdoses hitting a record level a year ago, policy change in Washington State will implement change.
Recommendations
Prescription Drug Monitoring Programs (2017), is a strategy that shows the most evidence to back the effectiveness to enhance opioid prescribing and protect its patients. Recent years, states have authorized bills to command PDMP registration for providers, figure out who can get to the
PDMP on behalf of the prescribers, set the period inside which to report dispensing of prescribed
opioids and when to establish a requirement check of PDMP before prescribing again (PDMP,2017). In two studies, showing that PDMP could inform the providers when prescribing drugs based on the patient behavior and it'll improve the effectiveness of prescribing the correct dosage. (PDMP, 2017).
In many states, they are now providing Naloxone. Naloxone is a medicine that can turn around an opioid overdose (Kerensky, T and Walley, A J., 2017). Notwithstanding laws were made to ensure this medicine has immunity; the immunity would be accessible for dispensing, administering, and carrying (Kerensky, T and Walley, A J., 2017). Officials have been expanding access to naloxone. For instance, states would give a third party prescription for naloxone and pharmacists can dispense this medicine without a prescription to stop or prevent an
opioid overdose (Kerensky, T, and Walley, A J., 2017). In other laws, it only allows sure people to carry and use the drug they could include family and companions, school faculty, law requirement and emergency personnel.
Pain management clinics is a recommendation for this related public health problem. Its treatment will be focused on chronic pain (Rosenblum, A et al., 2008). Regulations of these clinics are focused on licensing. However, pain clinics prescribe based on the financial gain rather the medical need (Rosenblum, A et al., 2008). In this case, a pain management clinic can
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
often overprescribe opioids, and it can lead to misuse and abuse of drugs. Laws have shown this to be accurate within different states and it been seen to be an issue amongst some pain clinics (Rosenblum, A et al., 2008). The way to reduce this is through proper training of professionals (Rosenblum, A et al., 2008). Its required from all states to have educational training sessions that
are related to opioids, these training could include the control of over-prescribing, pain management and the identification of substance use or abuse.
A recent study showed how in a patient-centered medical home (PCMH), patients suffering from
pain gained more utilization from a patient-centered practice. The overall outcome of this study showed that patients with chronic pain had an improvement once they participated in the pain clinic (Elder NC et al., 2012). With the utilization of a chronic care model, patients with chronic pain than achieved the goal of combating chronic pain through pain management clinics. (Elder NC et al., 2012). This model would draw on different segments of care, for example, self-
management, clinical data, community resources, supportive decision making, and various measures to enhance the nature of attention given to patients with chronic pain and enhance providers fulfillment (Elder NC et al., 2012). The IOM, in its report about constant pain management, has required a customized way to deal with pain care, using self-management strategies in the primary care center, pain management clinics and specialty clinics (Elder NC et al., 2012). The IOM likewise recognizes that most pain care ought to be given by primary care doctors (Elder NC et al., 2012). Training is seen to enhance the delivery of chronic pain, from a provider point of view and organizations have now suggested that training care rules be executed
for use by the individuals who furnish nurture patients with chronic pain (Elder NC et al., 2012).
Research continues to about studied for prescribing opioids strategies. Over time, there will be a constant need to refine this growing confirmation base to guarantee that pain management intervention is a piece of a larger facilitated system that backings enhanced patient care and safety. Pushing ahead, leaders in the U.S. healthcare system must figure out how to adjust contending requests, for example, quickly reacting to an advancing general health care crisis with the need to gather information, thoroughly assess endeavors, and growing prescribed procedures for future execution.
Stakeholders should likewise adjust the need to diminish recommending rehearses that pushed prompt the present emergency while additionally safeguarding access to opioids as a piece of proper pain management. Strategies help the stakeholders as they try to part a safety net in place for prescribing the appropriate amount of opioids. For this reason, the efforts all come with the importance of the US healthcare system . Treatment for substance disorder is the key for overdose prevention, misuse of opioids and the abuse of illicit drugs.
In conclusion, this epidemic will also cause a stigma. When those patient is receiving legally prescribed opioids for any condition, it gives a negative stereotype. One recommendation was self-management, yet high levels of this stigma cause social isolation, low self-esteem, self-
efficacy (Livingston, J. D et al., 2012). Legally receiving opioids for a condition discourage one from getting help because of the stigma it puts a damper on advocacy attempts in the community (Livingston, J. D et al., 2012). Since the opioid epidemic is a prevalent health concern, it's recognized as a medical illness. Overall Prescribed Opioids will always remain a challenge when
treating chronic pain. New policies arise daily to ensure strategies are appropriately used and effective. More research is needed to show a total decline in opioid misuse and abuse.
References
Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction (Abingdon, England), 107(1), 39–50. http://doi.org/10.1111/j.1360-0443.2011.03601.x
Elder NC, Simmons T, Regan S, Gerrety E. Care for patients with chronic nonmalignant pain
with and without chronic opioid prescriptions: a report from the Cincinnati Area Research Group
(CARinG) Network. J Am Board Fam Med 2012;25:652–60.
Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008). Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions. Experimental and Clinical
Psychopharmacology, 16(5), 405–416. http://doi.org/10.1037/a0013628
Dowell D, Haegerich TM, Chou R. (2016). CDC Guideline for Prescribing Opioids for Chronic
Pain —United States. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1.
Center of Disease and Control. (2016). Calculating Total Daily Dose of Opioids For Safer.
https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf
The Bree Collaborative AMDG Opioid Prescribing Guidelines Implementation Workgroup
Charter (2015). Guideline on Prescribing Opioids for Pain.
King, N. B., Fraser, V., Boikos, C., Richardson, R., & Harper, S. (2014). Determinants of
Increased Opioid-Related Mortality in the United States and Canada, 1990–2013: A Systematic Review. American Journal of Public Health, 104(8), e32–e42. http://doi.org/10.2105/AJPH.2014.301966
Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN. (2007).
Development and validation of the Current Opioid Misuse Measure. Pain. 130:144–156.
Belgrade MJ, Schamber CD, Lindgren BR. (2006). The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 7:671–681.
Paulozzi LJ, Jones C, Mack K, Rudd R. (2011). Vital signs: overdoses of prescription opioid pain relievers— the United States, 1999–2008. MMWR Morb Mortal Wkly Rep;60:1487–92.
Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008). Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions. Experimental and Clinical
Psychopharmacology, 16(5), 405–416. http://doi.org/10.1037/a0013628
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P (2009). Clinical
Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain : Official Journal of the American Pain Society, 10(2), 113–130. http://doi.org/10.1016/j.jpain.2008.10.008
Warner M, Chen LH, Makuc DM. (2009). Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief. ( 22):1–8.
Franklin, G., Sabel, J., Jones, C. M., Mai, J., Baumgartner, C., Banta-Green, C. J., Tauben, D. J.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
(2015). A Comprehensive Approach to Address the Prescription Opioid Epidemic in Washington
State: Milestones and Lessons Learned. American Journal of Public Health, 105(3), 463–469. http://doi.org/10.2105/AJPH.2014.302367
Crowley R, Kirschner N, Dunn AS, Bornstein SS. (2017). Health and Public Policy to Facilitate
Effective Prevention and Treatment of Substance Use Disorders Involving Illicit and Prescription
Drugs: An American College of Physicians Position Paper. Ann Intern Med.166:733–736. doi: 10.7326/M16-2953
Chou R, Deyo R, Devine B, et al. (2017). The effectiveness and risks of long-term opioid treatment of chronic pain. Evidence Report/Technology Assessment No. 218. AHRQ Publication
No. 14-E005- EF. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved from http://www.effectivehealthcare.ahrq.gov/ehc/products/557/1971/chronic-pain-opioid-
treatmentreport-141007.pdf2014.
Washington State Department of Health. (2013). Drug poisoning and overdose
Washington State Department of Health. (2016). Legislative response
PDMP Center of Excellence at Brandeis University. (2013). Using PDMPs to Improve Medical
Care: Washington State's Data Sharing Initiative with Medicaid and Workers' Compensation. Notes from the Field, NF 4.1
Poon, Sabrina J. et al. ( 2014). The Opioid Prescription Epidemic and the Role of
Emergency Medicine Annals of Emergency Medicine, Volume 64, Issue 5, 490 – 495
Centers for Disease Control and Prevention. (2011). Policy impact: prescription painkiller
overdoses
Kerensky, T and Walley, A J. (2017). "Opioid Overdose Prevention and Naloxone Rescue Kits:
What We Know and What We Don't Know." Addiction Science & Clinical Practice 12 :4. PMC. Overdose is now the leading cause of accidental death
Optum (2016). Origins of the Opioid Epidemic
Overdose is now the leading cause of accidental death https://www.optum.com/resources/library/origins-opioid-epidemic.html